GLP-1 receptor agonists × body weight & composition

TrialThe New England journal of medicine2015

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.

Xavier Pi-Sunyer et al.PubMed ↗Publisher ↗

What the trial testedrandomised · 3,731 people · 2015

Randomised comparison

Lowered body weight & composition

−5.60kg−6.00 to −5.10

As reported

difference −5.6 kg, 95% CI −6.00 to −5.10

One number in the abstract

the abstract, start to end

a mean of 2.8±6.5 kg (a difference of -5.6 kg; 95% confidence interval,

← favours treatmentfavours comparator →
could be chance
Body weight & composition
−5.6−6.00 to −5.10
GLP-1 receptor agonistsBody weight & composition

GLP-1 receptor agonists × body weight & compositionhelps?replicated

unlikelylikely
0.900.91 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

1,138 papers cite itlatest 60 shown

2015
2025
2026
this paperpooled ittrialcites it

7 trials

Full record →Abstract, authors, funding and every citing paper · PMID 26132939